Correlation Between Upstream Bio, and Viemed Healthcare

Can any of the company-specific risk be diversified away by investing in both Upstream Bio, and Viemed Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Upstream Bio, and Viemed Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Upstream Bio, and Viemed Healthcare, you can compare the effects of market volatilities on Upstream Bio, and Viemed Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Upstream Bio, with a short position of Viemed Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Upstream Bio, and Viemed Healthcare.

Diversification Opportunities for Upstream Bio, and Viemed Healthcare

0.75

Correlation Coefficient

Upstream Bio,  Viemed Healthcare

Poor diversification

The 3 months correlation between Upstream and Viemed is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Upstream Bio, and Viemed Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viemed Healthcare and Upstream Bio, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Upstream Bio, are associated (or correlated) with Viemed Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viemed Healthcare has no effect on the direction of Upstream Bio, i.e., Upstream Bio, and Viemed Healthcare go up and down completely randomly.

Pair Corralation between Upstream Bio, and Viemed Healthcare

Considering the 90-day investment horizon Upstream Bio, is expected to generate 2.65 times more return on investment than Viemed Healthcare. However, Upstream Bio, is 2.65 times more volatile than Viemed Healthcare. It trades about 0.02 of its potential returns per unit of risk. Viemed Healthcare is currently generating about 0.0 per unit of risk. If you would invest  1,700  in Upstream Bio, on October 4, 2024 and sell it today you would lose (71.00) from holding Upstream Bio, or give up 4.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	15.78%
Values	Daily Returns

Upstream Bio,  vs.  Viemed Healthcare

Upstream Bio,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Upstream Bio, may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Viemed Healthcare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Viemed Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Viemed Healthcare is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Upstream Bio, and Viemed Healthcare

The main advantage of trading using opposite Upstream Bio, and Viemed Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Upstream Bio, position performs unexpectedly, Viemed Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viemed Healthcare will offset losses from the drop in Viemed Healthcare's long position.

The idea behind Upstream Bio, and Viemed Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.